Bedside Assessment of Downgaze Limit by Amplitude
Movement Disorders Clinical Practice · 2025-12 · 12 (12) · 2224-2231
DOI: 10.1002/mdc3.70221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 10.07.2025. Verfasst von Tao Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Parkinson Disease, Point-of-Care Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Bedside assessment of downgaze palsy could be difficult, due to the lack of a marker to differentiate normal from palsy, which could delay the diagnosis of progressive supranuclear palsy (PSP). Amplitude based bedside assessment using the intercanthal line as a marker was reported to easily identify, quantify, and record downgaze limit by any smartphone. However, further assessment is needed.
Objective
To study the reliability of this method in assessing downgaze limit.
Methods
We assessed downgaze limit by amplitude in 36 healthy controls (HC), 50 patients with Parkinson's disease (PD), and 23 with probable PSP when they strived to look down. We also checked the intra‐rater agreement in another 18 patients with probable PSP by a neurologist, inter‐rater agreement between two neurologists, and intra‐rater agreement between visual estimation and smartphone acquired eye imaging based quantification in probable PSP, PD, and HC. The association between the extent of downgaze palsy and brain atrophy in MRI was also evaluated in patients with probable PSP.
Results
None of the 86 non‐PSP subjects had upper edges of the iris above the intercanthal line (downgaze palsy absent), while the 41 patients with probable PSP all had upper edges of the iris above the intercanthal line (downgaze palsy present). We also found a high intra‐rater agreement by a neurologist, inter‐rater agreement between two neurologists, intra‐rater agreement between visual estimation and imaging quantification, and association between the extent of downgaze palsy and brain atrophy.
Conclusions
This study supports this bedside assessment, with significant clinical and research applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The University of Chicago, Chicago, IL, USA.
- Department of Radiology, The University of Chicago, Chicago, IL, USA.
- Department of Public Health, The University of Chicago, Chicago, IL, USA.
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, USA.
Zitieren
APA
Xie, T., Padmanaban, M., Collins, J., Liao, C., Abou Chaar, W., Bundy, J., & Nichols, J. (2025). Bedside Assessment of Downgaze Limit by Amplitude. Movement Disorders Clinical Practice, 12(12), 2224-2231. https://doi.org/10.1002/mdc3.70221
Vancouver
Xie T, Padmanaban M, Collins J, Liao C, Abou Chaar W, Bundy J, et al. Bedside Assessment of Downgaze Limit by Amplitude. Movement Disorders Clinical Practice. 2025;12(12):2224-2231. doi:10.1002/mdc3.70221
BibTeX
@article{Xie2025,
author = {Xie, Tao and Padmanaban, Mahesh and Collins, John and Liao, Chuanhong and Abou Chaar, Widad and Bundy, Jonathan and Nichols, Jeffrey},
title = {Bedside Assessment of Downgaze Limit by Amplitude},
journal = {Movement Disorders Clinical Practice},
year = {2025},
volume = {12},
number = {12},
pages = {2224--2231},
doi = {10.1002/mdc3.70221}
}
EUVIMED